Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes

Metabolism: Clinical and Experimental

Volumn 62, Issue 8, 2013, Pages 1149-1158

  Kumar, Prabhakaran ^a   Raghavan, Somasundaram ^a   Shanmugam, Gobinath ^a   Shanmugam, Narkunaraja ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

ABCA1; Diabetes; LXR; THP 1 cells

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; ABC TRANSPORTER G8; ADVANCED GLYCATION END PRODUCT; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LUCIFERASE; MESSENGER RNA; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ABCA1; ADVANCED GLYCATION END PRODUCTS; AGE; ATP-BINDING CASSETTE TRANSPORTER A1; DIABETES; LDL; LIVER X RECEPTORS; LOW DENSITY LIPOPROTEIN; LXR; THP-1 CELLS;

ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CELL SEPARATION; DIABETES MELLITUS; HUMANS; LUCIFERASES; MACROPHAGES; MONOCYTES; NERVE GROWTH FACTORS; ORPHAN NUCLEAR RECEPTORS; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; RNA; S100 PROTEINS; TRANSFECTION;

EID: 84880572386     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.02.006     Document Type: Article

References (46)

1. J.A. Beckman, M.A. Creager, and P. Libby Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JAMA 287 2002 2570 2581
2. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
3. C.K. Glass, and J.L. Witztum Atherosclerosis: the road ahead Cell 104 2001 503 516
4. Y. Yamauchi, C.C. Chang, and M. Hayashi Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein mediated assembly of high density lipoprotein in fibroblasts J Lipid Res 45 2004 1943 1951
5. S. Porchay-Balderelli, F. Pean, and N. Emery Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus Metabolism 58 2009 74 79
6. A. Sandhofer, B. Iglseder, and S. Kaser The influence of two variants in the adenosine triphosphate-binding cassette transporter 1 gene on plasma lipids and carotid atherosclerosis Metabolism 57 2008 1398 1440
7. D.C. Patel, C. Albrecht, and D. Pavitt Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression Protein and Function. PLoS One 6 2011 e22142
8. A. Calkin, and P. Tontonoz LXR signaling pathway and atherosclerosis Atheroscler Thromb Vasc. Biol. 30 2010 1513 1518
9. B.A. Janowski, P.J. Willy, and T.R. Devi An oxysterol signaling pathway mediated by the nuclear receptor LXR alpha Nature 383 1996 728 731
10. P.J. Willy, K. Umesono, and E.S. Ong LXR, a nuclear receptor that defines a distinct retinoid response pathway Genes Dev 9 1995 1033 1045
11. R. Kaplan, X. Gan, and J.G. Menke Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway J Lipid Res 43 2002 952 959
12. F.J. Field, K. Watt, and S.N. Mathur TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2 J Lipid Res 51 2010 1407 1415
13. M.C. Gerbord-Giannone, Y. Li, and A. Holleboom TNF-α induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells Proc Natl Acad Sci 103 2006 3113 3117
14. A. Chawla, W.A. Boisvert, and C.H. Lee A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol Cell Biol 7 2001 161 171
15. Y. Zhu, H. Liao, and X. Xie Oxidized LDL down regulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor Cardiovasc Res 68 2005 425 432
16. A.M. Schmidt, M. Vianna, and M. Gerlach Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 267 1992 14987 14997
17. D.X. Bu, V. Rai, and X. Shen Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice Circ Res 106 2010 1040 1051
18. K.C. Tan, W.S. Chow, and V.H. Ai Advanced glycation end-products and endothelial dysfunction in type 2 diabetes Diabetes Care 25 2002 1055 1059
19. G. Basta, A.M. Schmidt, and R.D. Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592
20. L.J. Sparvero, D.A. Asafu-Adjei, and R. Kang RAGE (receptor for advanced glycation end products), RAGE ligands, and their role in cancer and inflammation J Transl Med 7 2009 17
21. N. Shanmugam, R.M. Ransohoff, and R. Natarajan Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100B J Biol Chem 281 2006 31212 31221
22. N. Shanmugam, Y.S. Kim, and L. Landing Regulation of COX-2 expressions in monocytes by ligation of the receptor for advanced glycation endproducts J Biol Chem 278 2003 34834 34844
23. N. Shanmugam, M.A. Reddy, and R. Natarajan Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100B, a ligand of the receptor for advanced glycation end products J Biol Chem 283 2008 36221 36233
24. J.N. Tsoporis, A. Marks, and A. Haddad S100B expression modulates left ventricular remodeling after myocardial infarction in mice Circulation 111 2005 598 606
25. M. Passarelli, C. Tang, and T.O. McDonald Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells Diabetes 54 2005 2198 2205
26. K. Isoda, E.J. Folco, and K. Shimizu AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL Atherosclerosis 192 2007 298 304
27. Y. Zhang, Z. Luo, and L. Ma Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator activated receptor-γ activation Int J Mol Med 25 2010 729 734
28. S. Takashiba, T.E. Van dyke, and S. Amar Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor κB Infect Immun 67 1999 5573 5578
29. M. Daigneault, J.A. Preston, and H.M. Marriott The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages PLoS One 5 2010 e8668
30. S. Raghavan, G. Subramaniam, and N. Shanmugam Proinflammatory effects of malondialdehyde in lymphocyte J. Leuk Biol. 92 2012 1055 1067
31. T. Kislinger, N. Tanji, and T. Wendt RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice Arterioscler Thromb Vasc Biol 21 2001 905 910
32. L.G. Bucciarelli, T. Wendt, and W. Qu RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice Circulation 106 2002 2827 2835
33. M. Oimomi, N. Igaki, and F. Hata Age and diabetes accelerated glycation in the human aorta Arch Gerontol Geriatr 8 1989 123 127
34. K. Inoue, K. Kawahara, and K.K. Biswas HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques Cardiovasc Pathol 16 2007 136 143
35. A.P. Burke, F.D. Kolodgie, and A. Zieske Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler Thromb Vasc Biol 24 2004 1266 1271
36. M.A. Hofmann, S. Drury, and C. Fu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulins polypeptides Cell 97 1999 889 901
37. T. Ostendorp, E. Leclerc, and A. Galichet Structural and functional insights into RAGE activation by multimeric S100B EMBO J 26 2007 3868 3878
38. A. Venkateswaran, B.A. Laffitte, and S.B. Joseph Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha Proc Natl Acad Sci 97 2000 12097 12102
39. I.C. Gelissen, M. Harris, and K.A. Rye ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I Arterioscler Thromb Vasc Biol 26 2006 534 540
40. C.L. Wellington, E.K. Walker, and A. Suarez ABCA1 mRNA and protein distribution patterns predict multipledifferent roles and levels of regulation Lab Invest 82 2002 273 283
41. E. Leclerc, G. Fritz, and M. Weibel S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains J Biol Chem 282 43 2007 31317 31331
42. Y. Takata, V. Chu, and A.R. Collins Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic affect of angiotensin II Circ Res 97 2005 e88 e96
43. M. Chen, W. Li, and N. Wang ROS and NF-κB but not LXR mediate IL-1β signaling for the downregulation of ATP-binding cassette transporter A1 Am J Physiol Cell Physiol 292 4 2007 1493 1501
44. S. Santamarina-Fojo, K. Peterson, and C. Knapper Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A1 promoter Proc Natl Acad Sci 97 2000 7987 7992
45. X.P. Yang, L.A. Freeman, and C.L. Knapper The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene J Lipid Res 43 2002 297 306
46. J. Wong, C.M. Quinn, and A.J. Brown Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol flux Arterioscler Thromb Vasc Biol 24 2004 2365 2371